STOCKWATCH
·
Pharmaceuticals
Quarterly Result5 Nov 2025, 02:38 pm

Procter & Gamble Health Ltd Announces Q3 2025 Financial Results with 94.45% YoY Revenue Growth

AI Summary

Procter & Gamble Health Ltd, a leading player in the healthcare industry, has announced its financial results for the quarter ended September 30, 2025. The company reported a significant revenue growth of 94.45% YoY. The total income for the quarter stood at INR 32,987 Lakhs as compared to INR 16,994 Lakhs in the corresponding quarter of the previous year. The profit before tax was INR 8,881 Lakhs, a substantial increase from INR 4,902 Lakhs in the same quarter of the previous year. The company's net profit for the quarter was INR 8,854 Lakhs, up from INR 6,618 Lakhs in the same quarter of the previous year. The company's earnings per equity share (before exceptional items) stood at INR 8.85, up from INR 6.62 in the same quarter of the previous year.

Key Highlights

  • Revenue growth of 94.45% YoY
  • Profit before tax at INR 8,881 Lakhs
  • Net profit at INR 8,854 Lakhs
  • Earnings per equity share (before exceptional items) at INR 8.85
PGHL
Pharmaceuticals
Procter & Gamble Health Ltd

Price Impact